cancer

A study in the Indian Journal of Pain found nurse-led reassessment raised meaningful cancer pain relief from 38 percent to 80 percent of patients.

India has capped trade margins on non-scheduled cancer medicines at 30 percent, with a revised list of 543 brands taking effect on 9 November 2026.

The Supreme Court reserved its verdict after questioning how a cancer injection costing a dealer Rs 11,000 could be charged to a patient at Rs 1.30 lakh.

Mass General Brigham researchers built an AI that estimates cancer survival from a single face photo, publishing results in Lancet Digital Health.

Mass General Brigham scientists built a cancer survival AI trained on 40 million facial photos to predict a patient's survival odds from one selfie.